Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NXL104/Ceftazidime + Metronidazole vs Meropenem in cIAI
NCT00752219Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of avibactam in Intra-abdominal infection (IAI), sponsored by Pfizer. Started Mar 2009; status: completed.
02
Drugs
avibactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00752219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752219.